Search for: "AMGEN, INC" Results 161 - 180 of 702
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jun 2020, 7:42 pm by Bloomberg
., Apple Inc. and Amgen Inc. are among more than a dozen companies supporting Harvard University in a fierce legal battle that could shape the use of race in college admissions for decades to come. [read post]
14 Jan 2010, 1:01 am by Dr. Shezad Malik
Amgen Inc. and Johnson & Johnson face a review of their top-selling anemia drugs by an advisory panel for the U.S. [read post]
17 Apr 2007, 10:46 am
Amgen-Sponsored Study Was Testing Aranesp In Cancer Patients Who Developed Anemia (Posted by Tom Lamb at DrugInjuryWatch.com) An April 17, 2007 Wall Street Journal (WSJ) article about the results of a new study concerning Aranesp revealed more bad news for Amgen Inc., the maker of this anemia drug:Amgen's drug Aranesp didn't reduce the need for blood transfusions in anemic cancer patients and was linked to a nearly 45% increase in deaths compared with patients… [read post]
4 Oct 2023, 5:27 pm by Scott McKeown
As a reminder the SCOTUS in Amgen warned that “the more one claims, the more one must enable” Amgen Inc. v. [read post]
27 Apr 2009, 9:55 pm
By Donald Zuhn -- Johnson & Johnson: 5-Year Exclusivity Period Would Kill Incentives to Innovate Last month, Amgen Inc. [read post]
11 Jul 2012, 10:22 am by Matthew Huisman
Michael Petty, the former vice president of development and regulatory law at biotechnology company Amgen Inc., joins King & Spalding in its Washington office. [read post]
2 Apr 2016, 4:00 am by Steve Brachmann
The post Injectable migraine treatment being developed by Alder, Eli Lilly, Amgen and others appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
20 Mar 2008, 10:01 pm
Switzerland based Biotechnology Company; Roche Holding AG who developed pegylated version of Erythropoietin (MIRCERA ®) said on Tuesday that they agreed to conditions set by the federal judge of the United States district court of Massachusetts, overseeing a patent case brought by Amgen Inc, which could clear the way for Roche to sell its anemia drug MIRCERA ® in the United States. [read post]
27 Mar 2007, 3:29 pm
Amgen Inc. has recently filed this new cert. petition in the case of Amgen v. [read post]
16 Jun 2020, 9:59 pm by Patent Docs
Amneal Pharmaceuticals LLC) and its related limiting doctrines, prosecution history estoppel (Amgen Inc. v. [read post]
26 Feb 2015, 9:43 am by Morse, Barnes-Brown Pendleton
Brougher On February 18, 2015, Apotex Inc., announced that the Food and Drug Administration (FDA) had accepted its application for a biosimilar version of Amgen Inc’s Neupogen®. [read post]
19 Nov 2012, 9:34 am
Along with the Comcast lawsuit is another class action lawsuit against the biotech company, Amgen, Inc. [read post]